Olukemi Aina, | |
400 N Highland Ave, Aurora, IL 60506-3814 | |
(630) 394-8926 | |
Not Available |
Full Name | Olukemi Aina |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Psychiatric/mental Health |
Location | 400 N Highland Ave, Aurora, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124787650 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 209024364 (Illinois) | Primary |
Entity Name | Presence Behavioral Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477622298 PECOS PAC ID: 7517864143 Enrollment ID: O20040319001574 |
News Archive
New research provides insights on how to restore the ability to ejaculate in men who are not able to do so.
A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients.
Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine.
› Verified 5 days ago
Entity Name | Thriveworks Telepsychiatry - Illinois |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154099620 PECOS PAC ID: 4587035225 Enrollment ID: O20230117002207 |
News Archive
New research provides insights on how to restore the ability to ejaculate in men who are not able to do so.
A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients.
Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Olukemi Aina, 400 N Highland Ave, Aurora, IL 60506-3814 Ph: (630) 978-2532 | Olukemi Aina, 400 N Highland Ave, Aurora, IL 60506-3814 Ph: (630) 394-8926 |
News Archive
New research provides insights on how to restore the ability to ejaculate in men who are not able to do so.
A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients.
Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine.
› Verified 5 days ago
Courtney Harley, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2720 E New York St, Ste 108, Aurora, IL 60502 Phone: 630-820-7045 Fax: 630-820-7047 | |
Tochi Okwueze, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Heidijo Elyea, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1256 Waterford Drive, Suite 120, Aurora, IL 60504 Phone: 630-499-6688 Fax: 630-499-6689 | |
Mrs. Haley S.v. Murphy, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-892-4355 | |
Ms. Carole Wolfson, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 581 Sullivan Rd Ste B, Aurora, IL 60506 Phone: 630-859-3877 Fax: 630-859-8920 | |
Ms. Kenisha Francisco, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Terra L Kolacki, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 444 N Eola Rd Ste 110, Aurora, IL 60502 Phone: 630-692-5660 Fax: 630-692-5661 |